1-7 of 7
Jeanette Ampudia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Blocking the CD6-Alcam Pathway Prevents Trans Endothelial Migration of Pathogenic Effector T Cells

Valeria Marrocco, Jeanette Ampudia, Cherie Ng, Stephen Connelly
Journal: Blood
Blood (2022) 140 (Supplement 1): 12657–12658.
https://doi.org/10.1182/blood-2022-170294
Published: 2022
Journal Articles

CD6 Is a Modulator of Treg Differentiation and Activity

Jeanette Ampudia, Dalena Chu, Stephen Connelly, Cherie Ng
Journal: Blood
Blood (2022) 140 (Supplement 1): 12653–12654.
https://doi.org/10.1182/blood-2022-170268
Published: 2022
Journal Articles

Antigenic Modulation of CD6 By Itolizumab Is a New Mechanism for Effector T Cell Inhibition

Dalena Chu, Valeria Marrocco, Phoi Tiet, Jeanette Ampudia, Stephen Connelly, Cherie Ng
Journal: Blood
Blood (2021) 138 (Supplement 1): 995.
https://doi.org/10.1182/blood-2021-148805
Published: 2021
Journal Articles

Early Reconstitution of CD6+ T Cells after Hematopoietic Cell Transplantation Identifies a Suitable Target for Acute Graft Versus Host Disease Treatment Using Anti-CD6 Monoclonal Antibody Itolizumab

Benedetta Rambaldi, MD, Haesook T. Kim, PhD, Carol Reynolds, PhD, Sharmila Chamling Rai, BSc, Takeru Asano, MD PhD, Yohei Arihara, MD PhD, Mahasweta Gooptu, MD, John Koreth, MBBS, DPhil, Corey Cutler, MD MPH, FRCPC, Sarah Nikiforow, MD PhD, Vincent T. Ho, MD, Joseph H. Antin, MD, Rizwan Romee, MD, Robert J. Soiffer, MD, Jeanette Ampudia, Cherie Tracy Ng, PhD MPH, Stephen Connelly, PhD MBA, Jerome Ritz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-138710
Published: 2020
Journal Articles

Impact of Itolizumab on the Expression of CD6 and the Function of Effector T Cells

Jeanette Ampudia, Dalena Chu, MS, Jana Badrani, MS, Taylor Doherty, MD, Stephen Connelly, PhD MBA, Cherie Tracy Ng, PhD MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-141638
Published: 2020
Journal Articles

Anti-CD6 Monoclonal Antibody Itolizumab Efficiently Inhibits T Cell Proliferation after in Vitro TCR Stimulation in the Setting of Acute Graft Versus Host Disease

Benedetta Rambaldi, MD, Carol Reynolds, PhD, Sharmila Chamling Rai, BSc, Takeru Asano, MD PhD, Yohei Arihara, MD PhD, Mahasweta Gooptu, MD, John Koreth, MBBS, DPhil, Corey Cutler, MD MPH, FRCPC, Sarah Nikiforow, MD PhD, Vincent T. Ho, MD, Edwin P. Alyea, III, MD, Joseph H. Antin, MD, Rizwan Romee, MD PhD, Robert J. Soiffer, MD, Domenico Russo, MD, Jeanette Ampudia, BSc, Cherie Tracy Ng, PhD MPH, Stephen Connelly, PhD MBA, Jerome Ritz, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4517.
https://doi.org/10.1182/blood-2019-125721
Published: 2019
Journal Articles

Itolizumab As a Potential Therapeutic for the Prevention and Treatment of Graft Vs Host Disease

Cherie Tracy Ng, PhD MPH, Jeanette Ampudia, BSc, Robert J. Soiffer, MD, Jerome Ritz, MD, Stephen Connelly, PhD MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 5603.
https://doi.org/10.1182/blood-2019-122787
Published: 2019